UM Ventures News
First Stereotactic Radiation Therapy System Designed to Treat Early Stage Breast Cancer Receives FDA Clearance
Friday, December 29, 2017
The GammaPod ™ is a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer, and is paving the way to bring the system to market.
DOTmed: FDA Greenlights Clearance of GammaPod Stereotactic Radiotherapy System
Friday, December 29, 2017
The FDA has given the green light for the clearance of a noninvasive stereotactic radiotherapy system in the treatment of breast cancer.
BBJ: UMB Startup Raises $3 Million, Adding to Big Year
Thursday, December 28, 2017
Technical.ly: These 12 Baltimore Startups Got Acquired in 2017
Thursday, December 21, 2017
A string of exits was one of the defining stories for Baltimore's tech community this year.
How Harpoon Medical’s Exit Can Produce Returns for Baltimore
Tuesday, December 19, 2017
gel-e Receives US FDA Clearance to Expand its Bandage Product Line for Rx and OTC Use
Friday, December 15, 2017
This new bandage clearance expands the Company's label to include the management of moderately to heavily exuding chronic wounds and acute wounds.
UM Carey Intellectual Property Clinic Expanding Services for Entrepreneurs
Friday, December 15, 2017
BBJ: UMB's Harpoon Medical was snatched up for $100 Million. Here's How it Impacts the School
Monday, December 11, 2017
![The Grid in the UM BioPark. The Grid in the UM BioPark.](https://www.umventures.org/sites/default/files/styles/medium/public/GRID-e1512755465783.jpg?itok=SXxDcKg6)
University of Maryland Baltimore looks beyond the BioPark with latest innovation hub
Friday, December 8, 2017